Surgery Partners rejected a buyout offer from Bain Capital, while Benchmark reiterated a 'Buy' rating on the company.
4 reports, 2 independent
Updated Jul 2
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Surgery Partners rejected a buyout offer from Bain Capital, while Benchmark reiterated a 'Buy' rating on the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Surgery Partners
healthcare services company
-
Bain Capital
American alternative investment firm specialized in private equity, venture capital and credit products
-
Benchmark
venture capital firm
- The Bank of England, FED, and market experts are discussing how the ongoing Iran conflict and geopolitical tensions are driving up energy costs and influencing global financial rates.
- MarketBeat published a buy rating and target price increase for a company, with disclosures made under a Rule 10b5-1 trading plan.
Related events
Coverage
Newest first; wire copies grouped- StockStorySurgery Partners (SGRY) Stock Trades Up, Here Is Why Shares of healthcare company Surgery Partners (NASDAQ:SGRY) jumped 4.3% in the morning session after Bank of America Securities resumed coverage o
- Insider MonkeySurgery Partners, Inc. (SGRY): A Bull Case Theory We came across a bullish thesis on Surgery Partners, Inc. on Valueinvestorsclub.com by Shoe. In this article, we will summarize the bulls’ thesis on